Your browser doesn't support javascript.
loading
Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes.
Kaur, Harpinder; Shekhar, Nishant; Sharma, Saurabh; Sarma, Phulen; Prakash, Ajay; Medhi, Bikash.
Afiliação
  • Kaur H; Department of Pharmacology, Post Graduate Institute of Medical Education and Reseasrch (PGIMER), Chandigarh, 160012, India.
  • Shekhar N; Department of Pharmacology, Post Graduate Institute of Medical Education and Reseasrch (PGIMER), Chandigarh, 160012, India.
  • Sharma S; Department of Pharmacology, Post Graduate Institute of Medical Education and Reseasrch (PGIMER), Chandigarh, 160012, India.
  • Sarma P; Department of Pharmacology, Post Graduate Institute of Medical Education and Reseasrch (PGIMER), Chandigarh, 160012, India.
  • Prakash A; Department of Pharmacology, Post Graduate Institute of Medical Education and Reseasrch (PGIMER), Chandigarh, 160012, India.
  • Medhi B; Department of Pharmacology, Post Graduate Institute of Medical Education and Reseasrch (PGIMER), Chandigarh, 160012, India. drbikashus@yahoo.com.
Pharmacol Rep ; 73(3): 736-749, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33389725

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ivermectina / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Pharmacol Rep Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ivermectina / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Pharmacol Rep Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia País de publicação: Suíça